(Q41019100)

25 September 2017

1 reference

title

Antidepressants and drug-metabolizing enzymes--expert group report (English)

1 reference

25 September 2017

U A Meyer

1

1 reference

25 September 2017

R Amrein

2

1 reference

25 September 2017

L P Balant

3

1 reference

25 September 2017

L Bertilsson

4

1 reference

25 September 2017

M Eichelbaum

5

1 reference

25 September 2017

T W Guentert

6

1 reference

25 September 2017

S Henauer

7

1 reference

25 September 2017

P Jackson

8

1 reference

25 September 2017

G Laux

9

1 reference

25 September 2017

H Mikkelsen

10

1 reference

25 September 2017

C Peck

11

1 reference

25 September 2017

B G Pollock

12

1 reference

25 September 2017

R Priest

13

1 reference

25 September 2017

F Sjöqvist

14

1 reference

25 September 2017

A Delini-Stula

15

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 February 1996

1 reference

Acta Psychiatrica Scandinavica

25 September 2017

published in

1 reference

25 September 2017

volume

93

1 reference

25 September 2017

issue

2

1 reference

25 September 2017

page(s)

71-79

1 reference

Polymorphic hydroxylation of Debrisoquine in man.

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1996.TB09805.X

Defective N-oxidation of sparteine in man: A new pharmacogenetic defect

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1996.TB09805.X

Characterization of the common genetic defect in humans deficient in debrisoquine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1996.TB09805.X

Two mutant alleles of the human cytochrome P-450db1 gene (P450C2D1) associated with genetically deficient metabolism of debrisoquine and other drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1996.TB09805.X

Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1996.TB09805.X

Pharmacogenetics: the slow, the rapid, and the ultrarapid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1996.TB09805.X

The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1996.TB09805.X

The pharmacogenetics of the selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1996.TB09805.X

Moclobemide treatment causes a substantial rise in the sparteine metabolic ratio. Danish University Antidepressant Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1996.TB09805.X

Interactions of moclobemide with concomitantly administered medication: evidence from pharmacological and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1996.TB09805.X

Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1996.TB09805.X

10.1111/J.1600-0447.1996.TB09805.X

21 January 2018

Identifiers

DOI

1 reference

25 September 2017

1 reference